Replies to post #376443 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

after the data release if it good i strongly believe the SP will trading above $40

$40 equates to an AVXL market cap of approximately $3 billion. I like that number as a very reasonable conservative estimate for the stock price assuming a successful trial meeting all primary endpoints. After all, SAVA has only Phase II data plus open label extension on Simufilam and it traded ten days ago at approximately $2 billion.